首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of the TB-Biochip Oligonucleotide Microarray System for Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis
【24h】

Evaluation of the TB-Biochip Oligonucleotide Microarray System for Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis

机译:快速检测结核分枝杆菌对利福平耐药性的TB-生物芯片寡核苷酸微阵列系统的评价

获取原文
           

摘要

The TB-Biochip oligonucleotide microarray system is a rapid system to detect mutations associated with rifampin (RIF) resistance in mycobacteria. After optimizing the system with 29 laboratory-generated rifampin-resistant mutants of Mycobacterium tuberculosis, we evaluated the performance of this test using 75 clinical isolates of Mycobacterium tuberculosis. With this small sample set, the TB-Biochip system displayed a sensitivity of 80% and a specificity of 100% relative to conventional drug susceptibility testing results for RIF resistance. For these samples (~50% tested positive), the positive predictive value was 100% and the negative predictive value was 85%. Four of the seven observed discrepancies were attributed to rare and new mutations not represented in the microarray, while three of the strains with discrepant results did not carry mutations in the RIF resistance-determining region. The results of this study confirm the utility of the system for rapid detection of RIF resistance and suggest approaches to increasing its sensitivity.
机译:TB-Biochip寡核苷酸微阵列系统是一种快速系统,可检测与分枝杆菌中的利福平(RIF)耐药相关的突变。在使用29个实验室产生的结核分枝杆菌抗利福平突变体优化系统后,我们使用75个结核分枝杆菌临床分离株评估了该测试的性能。相对于常规的RIF耐药性药敏试验结果,TB-Biochip系统具有如此小的样品集,显示出80%的灵敏度和100%的特异性。对于这些样本(〜50%测试阳性),阳性预测值为100%,阴性预测值为85%。在七个观察到的差异中,有四个归因于微阵列中未显示的罕见突变和新突变,而结果不一致的菌株中的三个在RIF抗性决定区域中未携带突变。这项研究的结果证实了该系统可用于快速检测RIF耐药性,并提出了提高其敏感性的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号